DOI QR코드

DOI QR Code

Suppression of green mold disease on oak mushroom cultivation by antifungal peptides

항진균성 펩티드에 의한 표고버섯 푸른곰팡이병의 억제

  • Lee, Hyoung-Jin (Department of Environmental and Biological Chemistry, Chungbuk National University) ;
  • Yun, Yeong-Bae (Department of Environmental and Biological Chemistry, Chungbuk National University) ;
  • Huh, Jeong-Hoon (Department of Environmental and Biological Chemistry, Chungbuk National University) ;
  • Kim, Young-Kee (Department of Environmental and Biological Chemistry, Chungbuk National University)
  • Received : 2017.05.06
  • Accepted : 2017.05.16
  • Published : 2017.06.30

Abstract

Contamination and growth of Trichoderma, a green mold, on the oak log and wooden chip or sawdust media can severely inhibit the growth of oak mushroom. Chemicals including pesticides and antibiotics are generally not allowed for the control of green mold disease during mushroom cultivation. In this study, bacterial pathogens causing blotch disease on the oyster mushrooms were isolated and their peptide toxins were purified for the control of green mold disease. Strains of Pseudomonas tolaasii secret various peptide toxins, tolaasin and its structural analogues, having antifungal activities. These peptides have shown no effects on the growth of oak mushrooms. When the peptide toxins were applied to the green mold, Trichoderma harzianum H1, they inhibited the growth of green molds. Among the 20 strains of peptide-forming P. tolaasii, strong, moderate, and weak antifungal activities were measured from 8, 5, and 7 strains, respectively. During oak mushroom cultivation, bacterial culture supernatants containing the peptide toxins were sprayed on the aerial mycelia of green molds grown on the surface of sawdust media. The culture supernatants were able to suppress the fungal growth of green molds while no effect was observed on the mushroom growth and production. They changed the color of molds from white aerial mycelium into yellowish dried scab, representing the powerful anti-fungal and sterilization activities of peptide toxins.

원목과 톱밥배지에서 푸른곰팡이의 오염과 성장은 표고버섯의 생장을 심하게 저해할 수 있다. 표고버섯 재배에서 푸른곰팡이병의 방제를 위하여 농약과 항생제와 같은 화학 약품의 사용은 일반적으로 허용되지 않는다. 본 연구에서는 푸른곰팡이병의 방제를 위하여 느타리버섯에서 갈반병을 일으키는 세균성 병원균을 분리하고 이들의 펩티드 독소를 분리하였다. Pseudomonas tolaasii 균주들은 항진균 활성을 갖는 톨라신 및 이와 구조적 유사체인 다양한 펩티드 독소를 분비한다. 이러한 펩티드들은 표고버섯의 생장에는 영향을 주지 않는다는 것이 알려져 있다. 펩티드 독소들을 Trichoderma harzianum H1 푸른곰팡이에 처리하였을 때, 푸른곰팡이의 성장을 저해하였다. 펩티드를 분비하는 20 종의 P. tolaasii 균주 중에서 강, 중, 약의 항진균 활성을 가진 균주의 수는 각각 8, 5, 7 종으로 나타났다. 표고버섯을 재배하는 동안에, 펩티드 독소를 함유한 세균 배양액에서 세균을 제거한 배양원액을 톱밥배지 표면에 자란 푸른곰팡이 균사에 분무하였다. 배양원액은 푸른곰팡이의 성장은 억제할 수 있는 반면, 표고버섯 생장과 생산에는 영향을 주지 않았다. 펩티드 독소를 함유하는 배양원액은 곰팡이의 흰색 균사체를 노란색의 마른 딱지로 변화시켰고, 이것은 펩티드 독소가 강력한 항진균 활성과 살균 활성을 갖고 있음을 보여준다.

Keywords

References

  1. Ait-Lahsen H, Soler A, Rey M, de La Cruz J, Monte E, Llobell A (2001) An antifungal exo-alpha-1,3-glucanase (AGN 13.1) from the biocontrol fungus Trichoderma harzianum. Appl Environ Microbiol 67: 5833-5839 https://doi.org/10.1128/AEM.67.12.5833-5839.2001
  2. Bae MJ, Kim KJ, Kim SJ, Ye EJ (2007) Effect of mycelia extracts from Lentinus edodes mushroom-cultured Astragalus membranaceus Bunge on anti-cancer and anti-allergy activities. J Kor Soc Food Sci Nutr 36: 8-13 https://doi.org/10.3746/jkfn.2007.36.1.008
  3. Bak WC, Kwon HJ (2005) Biology and control of pests and diseases in shiitake log cultivation. Mushroom Grower's Handbook, 2nd edn. MushWorld, Seoul, pp 152-161
  4. Cho KH, Park KS, Kim YK (2000) Hemolytic properties of tolaasin causing the brown blotch disease on oyster mushroom. J Korean Soc Agric Chem Biotechnol 43: 190-195
  5. Cho KH, Shin DS, Kim YK (2007) Effects of mushroom extracts on the growth and pathogenicity of Pseudomonas tolaasii, a pathogenic bacterium of brown blotch disease. J Agr Sci Chungbuk Nat'l Univ 23: 133-142
  6. Hatvani L, Antal Z, Manczinger L, Szekeres A, Druzhinina IS, Kubicek CP, Nagy A, Nagy A, Vagvolgyi C, Kredics L (2007) Green mold diseases of Agaricus and Pleurotus spp. are caused by related but phylogenetically different Trichoderma species. Phytopathology 97: 532-537 https://doi.org/10.1094/PHYTO-97-4-0532
  7. Hatvani L, Sabolic P, Kocsube S, Kredics L, Czifra D, Vagvolgyi C, Kaliterna J, Ivic D, Dermic E, Kosalec I (2012) The first report on mushroom green mould disease in Croatia. Arh Hig Rada Toksikol 63: 481-487 https://doi.org/10.2478/10004-1254-63-2012-2220
  8. Hikino H, Konno C, Mirin Y, Hayashi T (1985) Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Med 51: 339-340 https://doi.org/10.1055/s-2007-969507
  9. Jhune C, You CH, Cha DY, Kim GP (1990) Effects of thiabendazole on green mold, Trichoderma spp. during cultivation of oyster mushroom, Pleurotus spp. Kor J Mycol 18: 89-96
  10. Kim JW, Kim KH, Kang HJ (1994) Studies on the pathogenic Pseudomonas causing bacterial disease of cultivated mushroom in Korea: 1. On the causal organisms of the rots of Agaricus bisporus, Pleurotus ostreatus and Lentinus edodes. Kor J Plant Pathol 10: 197-210
  11. Kim JY, Kwon HW, Tang L, Kim SH (2012) Identification and characterization of Trichoderma citrinoviride isolated from mushroom fly-infested oak log beds used for shiitake cultivation. Plant Pathol J 28: 219 https://doi.org/10.5423/PPJ.2012.28.2.219
  12. Kweon MH, Kwon ST, Kwon SH, Ma MS, Park YI (2002) Lowering effects in plasma cholesterol and body weight by mycelial extracts of two mushrooms: Agaricus blazai and Lentinus edodes. Kor J Microbiol Biotechnol 30: 402-409
  13. Lee YS, Kim J, Lee SG, Oh E, Shin SC, Park IK (2009) Effects of plant essential oils and components from Oriental sweetgum (Liquidambar orientalis) on growth and morphogenesis of three phytopathogenic fungi. Pestic Biochem Phys 93: 138-143 https://doi.org/10.1016/j.pestbp.2009.02.002
  14. Lee YS, Kim J, Shin SC, Lee SG, Park IK (2008) Antifungal activity of Myrtaceae essential oils and their components against three phytopathogenic fungi. Flavour Fragr J 23: 23-28 https://doi.org/10.1002/ffj.1850
  15. Miyazaki K, Tsunoda M (2003) Application of DNA marker to research on Trichoderma in mushroom facilities of Japan (1): RAPD, SSCP marker. Mushroom Sci Biotechnol 11: 65-70
  16. Miyazaki K, Tsuchiya Y, Okuda T (2009) Specific PCR assays for the detection of Trichoderma harzianum causing green mold disease during mushroom cultivation. Mycoscience 50: 94-99 https://doi.org/10.1007/S10267-008-0460-2
  17. Seaby D (1998) Trichoderma as a weed mould or pathogen in mushroom cultivation. Trichoderma and Gliocladium CRC Press, London
  18. Sullivan R, Smith JE, Rowan NJ (2006) Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Bio Med 49: 159-170 https://doi.org/10.1353/pbm.2006.0034
  19. Wang G, Cao X, Ma X, Guo M, Liu C, Yan L, Bian Y (2016) Diversity and effect of Trichoderma spp. associated with green mold disease on Lentinus edodes in China. Microbiologyopen 5: 709-718 https://doi.org/10.1002/mbo3.364
  20. Watanabe S, Kumakura K, Kato H, Iyozumi H, Togawa M, Nagayama K (2005) Identification of Trichoderma SKT-1, a biological control agent against seedborne pathogens of rice. J Gen Plant Pathol 71: 351-356 https://doi.org/10.1007/s10327-005-0217-0
  21. Yamamoto Y, Shirono H, Kono K, Ohashi Y (1997) Immunopotentiating activity of the water-soluble lignin rich fraction prepared from LEM-the extract of the solid culture medium of Lentinus edodes mycelia. Biosci Biotechnol Biochem 61: 1909-1912 https://doi.org/10.1271/bbb.61.1909
  22. Yun YB, Park SW, Cha JS, Kim YK (2013) Biological characterization of various strains of Pseudomonas tolaasii that causes brown blotch disease. J Korean Soc Appl Biol Chem 56: 41-45 https://doi.org/10.1007/s13765-012-2242-y

Cited by

  1. Increase in antifungal activity by the combination of tolaasin and its analogue peptides vol.61, pp.1, 2018, https://doi.org/10.3839/jabc.2018.010
  2. High-Temperature Induced Changes of Extracellular Metabolites in Pleurotus ostreatus and Their Positive Effects on the Growth of Trichoderma asperellum vol.9, pp.1664-302X, 2018, https://doi.org/10.3389/fmicb.2018.00010